Cutaneous epithelioid angiosarcoma is a rare neoplasm of vascular endothelial cell origin that can mimic a cutaneous lymphoma, metastatic carcinoma, or Kaposi sarcoma. It is one of the most malignant cutaneous tumors and early diagnosis is essential, as the tumor metastasizes quickly. We describe a 75-year-old man who presented with three tender, indurated violaceous plaques on his scalp. Biopsy revealed a poorly circumscribed infiltrate extending into the subcutaneous fat, composed of atypical epithelioid cells lining vascular spaces. We provide a brief review of the clinical presentation, histopathologic features, differential diagnosis, and management of this rare tumor
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and syste...
Cutaneous angiosarcoma is a rare, highly malignant tumour of vascular endothelial origin. It usually...
Angiosarcomas are rare neoplasms of the head and neck region accounting for less than 1 % of maligna...
Cutaneous epithelioid angiosarcoma is a rare neoplasm of vascular endothelial cell origin that can m...
Cutaneous epithelioid angiosarcoma is a rare malignant vascular tumor, most commonly affecting elder...
We report on the cytologic features of a rare case of cutaneous epithelioid angiosarcoma of the scal...
Angiosarcoma is a cancer that is derived from endothelial cells that line blood vessels and lymphati...
Cutaneous angiosarcoma (CA) has a wide range of clinical presentations. In this case report, we disc...
Angiosarcomas are rare and only represent about 2% of all soft tissue sarcomas. They arise from vasc...
Cutaneous angiosarcoma of the head and neck is a rare, highly malignant neoplasm; prognosis is heavi...
Angiosarcoma (AS) is a rare malignant vascular tumor, which affects mainly elderly patients. After t...
Cutaneous angiosarcomas are rare but typically occur in three distinct clinical settings and are mos...
Cutaneous angiosarcoma is a rare and aggressive malignant tumor of vascular origin. Multimodality tr...
Abstract: Angiosarcoma is a rare and aggressive tumor with high rates of metastasis and relapse. It ...
Scalp angiosarcoma is a rare and highly malignant tumour originating from endothelial cells of vesse...
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and syste...
Cutaneous angiosarcoma is a rare, highly malignant tumour of vascular endothelial origin. It usually...
Angiosarcomas are rare neoplasms of the head and neck region accounting for less than 1 % of maligna...
Cutaneous epithelioid angiosarcoma is a rare neoplasm of vascular endothelial cell origin that can m...
Cutaneous epithelioid angiosarcoma is a rare malignant vascular tumor, most commonly affecting elder...
We report on the cytologic features of a rare case of cutaneous epithelioid angiosarcoma of the scal...
Angiosarcoma is a cancer that is derived from endothelial cells that line blood vessels and lymphati...
Cutaneous angiosarcoma (CA) has a wide range of clinical presentations. In this case report, we disc...
Angiosarcomas are rare and only represent about 2% of all soft tissue sarcomas. They arise from vasc...
Cutaneous angiosarcoma of the head and neck is a rare, highly malignant neoplasm; prognosis is heavi...
Angiosarcoma (AS) is a rare malignant vascular tumor, which affects mainly elderly patients. After t...
Cutaneous angiosarcomas are rare but typically occur in three distinct clinical settings and are mos...
Cutaneous angiosarcoma is a rare and aggressive malignant tumor of vascular origin. Multimodality tr...
Abstract: Angiosarcoma is a rare and aggressive tumor with high rates of metastasis and relapse. It ...
Scalp angiosarcoma is a rare and highly malignant tumour originating from endothelial cells of vesse...
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and syste...
Cutaneous angiosarcoma is a rare, highly malignant tumour of vascular endothelial origin. It usually...
Angiosarcomas are rare neoplasms of the head and neck region accounting for less than 1 % of maligna...